submitted by George Hurlburt

The Kabia family grieves as the body of their day-old daughter is removed from their home in the Hill Cut neighborhood of Freetown, Sierra Leone, by a member of a safe burial team. The government mandates that all deaths in Ebola-infested districts be treated as potential Ebola cases and buried in accordance with safety procedures.
Photograph by Pete Muller, Prime for National Geographic

To stop infected bodies from spreading the disease in Sierra Leone, health officials persuaded local leaders to change how villagers mourned.

nationalgeographic.com - by Amy Maxmen - January 30, 2015

FREETOWN, Sierra Leone—A great quarrel followed the death of a pregnant Guinean woman in June. Mourners refused to allow a team of outsiders dressed in what looked like white space suits to bury her Ebola-infected corpse. If she was to be saved from eternal wandering and reach the village of the dead, they insisted, her fetus must be removed.

(READ COMPLETE ARTICLE)

THOMPSON REUTERS By Misha Hussain                   Feb. 4, 2015

CONAKRY -- Medecins Sans Frontieres (MSF) made the "big mistake" of focusing too much on treatment early on in the Ebola epidemic rather than speaking to people about tackling the disease, a senior member of the medical charity said.

 ...With 20 years of experience of treating Ebola, MSF deployed hundreds to the Ebola "hot zones" and was quick to isolate patients and trace their contacts.

However, Claudia Evers, MSF's Ebola emergency coordinator in Guinea, said: "MSF made a big mistake. We advocated for an increase in beds for too long, and everyone listened to MSF."

"Instead of asking for more beds we should have asked for more sensitisation activities," Evers told the Thomson Reuters Foundation in an interview. Evers said the next stage of the Ebola response required a new approach if the disease was to be brought under control, centred on the promotion of good hygiene practices.

Read complete story
http://af.reuters.com/article/topNews/idAFKBN0L81SM20150204?sp=true

REUTERS    by Kate Kelland                                                                                 Feb. 3, 2014

LONDON  - Almost $2.9 billion was pledged by the end of 2014 in donations to fight West Africa's Ebola epidemic, yet only around 40 percent had actually reached affected countries, researchers said on Tuesday.

A study by the U.N. Office for the Coordination of Humanitarian Affairs that tracked international donations showed barely $1.09 billion had reached the worst affected countries by the end of last year, they said.

"These delays ... may have contributed to spread of the virus and could have increased the financial needs," said Karen Grepin, a global health policy expert at New York University who led the study and published it in the BMJ British medical journal.

Read full story.
http://news.yahoo.com/only-40-percent-ebola-funds-reached-target-countries-233343915.html

Link to full study.

International donations to the Ebola virus outbreak: too little, too late?

BRITISH MEDICAL JOURNAL   by  Karen A Grépin                                                      Feb. 3, 2015

BLOOMBERG  Commentary      by Charles Kenney                                              Feb. 3, 2015
...Without good surveillance, disease threats can fester undetected until they are considerably harder to contain. At the moment, countries simply declare they have the capacity to meet global standards and the WHO takes their word for it. There should be a system of independent review, backed up with international assistance and support to ensure that all countries really do have the capacity to track infectious disease outbreaks and control their spread across borders.

....the global health research system is primarily driven by market pressures. The cost of bringing a drug through the regulatory processes to market averages around $1 billion. That's a big reason why pharmaceutical companies would rather spend money on treatments for the diseases of the rich than for conditions that largely affect people in countries like Liberia...

There are two approaches to deal with that problem: lower the cost of drug development and increase the market for the products that emerge. ...

To increase demand, governments can club together to create an "advanced market commitment": If a drug developer produces a vaccine or therapy that meets certain standards, donors precommit to buy it in bulk....